Literature DB >> 19004938

Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells.

Tomoki Yoshikawa1, Terence Hill, Kui Li, Clarence J Peters, Chien-Te K Tseng.   

Abstract

Severe acute respiratory syndrome (SARS), which is caused by a novel coronavirus (CoV), is a highly communicable disease with the lungs as the major pathological target. Although SARS likely stems from overexuberant host inflammatory responses, the exact mechanism leading to the detrimental outcome in patients remains unknown. Pulmonary macrophages (Mphi), airway epithelium, and dendritic cells (DC) are key cellular elements of the host innate defenses against respiratory infections. While pulmonary Mphi are situated at the luminal epithelial surface, DC reside abundantly underneath the epithelium. Such strategic locations of these cells within the airways make it relevant to investigate their likely impact on SARS pathogenesis subsequent to their interaction with infected lung epithelial cells. To study this, we established highly polarized human lung epithelial Calu-3 cells by using the Transwell culture system. Here we report that supernatants harvested from the apical and basolateral domains of infected Calu-3 cells are potent in modulating the intrinsic functions of Mphi and DC, respectively. They prompted the production of cytokines by both Mphi and DC and selectively induced CD40 and CD86 expression only on DC. However, they compromised the abilities of the DC and Mphi in priming naïve T cells and phagocytosis, respectively. We also identified interleukin-6 (IL-6) and IL-8 as key SARS-CoV-induced epithelial cytokines capable of inhibiting the T-cell-priming ability of DC. Taken together, our results provide insights into the molecular and cellular bases of the host antiviral innate immunity within the lungs that eventually lead to an exacerbated inflammatory cascades and severe tissue damage in SARS patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004938      PMCID: PMC2655569          DOI: 10.1128/JVI.01792-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

Review 1.  Dendritic cells: immune regulators in health and disease.

Authors:  Mary F Lipscomb; Barbara J Masten
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 2.  Dendritic cells and viral immunity: friends or foes?

Authors:  D Kaiserlian; B Dubois
Journal:  Semin Immunol       Date:  2001-10       Impact factor: 11.130

Review 3.  Molecular structure of tight junctions and their role in epithelial transport.

Authors:  J M Anderson
Journal:  News Physiol Sci       Date:  2001-06

Review 4.  Origin and differentiation of dendritic cells.

Authors:  C Ardavín; G Martínez del Hoyo; P Martín; F Anjuère; C F Arias; A R Marín; S Ruiz; V Parrillas; H Hernández
Journal:  Trends Immunol       Date:  2001-12       Impact factor: 16.687

5.  Crosslinking CD81 results in activation of TCRgammadelta T cells.

Authors:  C T Tseng; E Miskovsky; G R Klimpel
Journal:  Cell Immunol       Date:  2001-01-10       Impact factor: 4.868

Review 6.  Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators.

Authors:  G J Randolph
Journal:  Semin Immunol       Date:  2001-10       Impact factor: 11.130

7.  Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.

Authors:  C T Tseng; E Miskovsky; M Houghton; G R Klimpel
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

Review 8.  Functional heterogeneity of colony-stimulating factor-induced human monocyte-derived macrophages.

Authors:  Kiyoko S Akagawa
Journal:  Int J Hematol       Date:  2002-07       Impact factor: 2.490

9.  Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.

Authors:  Chien-Te K Tseng; Gary R Klimpel
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

Review 10.  SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium.

Authors:  Amy C Sims; Susan E Burkett; Boyd Yount; Raymond J Pickles
Journal:  Virus Res       Date:  2007-04-23       Impact factor: 3.303

View more
  115 in total

Review 1.  The airway epithelium: soldier in the fight against respiratory viruses.

Authors:  Marjolaine Vareille; Elisabeth Kieninger; Michael R Edwards; Nicolas Regamey
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

2.  Primary severe acute respiratory syndrome coronavirus infection limits replication but not lung inflammation upon homologous rechallenge.

Authors:  Candice Clay; Nathan Donart; Ndingsa Fomukong; Jennifer B Knight; Wanli Lei; Lance Price; Fletcher Hahn; Jesse Van Westrienen; Kevin S Harrod
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 3.  Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.

Authors:  Esteban Ortiz-Prado; Katherine Simbaña-Rivera; Lenin Gómez-Barreno; Mario Rubio-Neira; Linda P Guaman; Nikolaos C Kyriakidis; Claire Muslin; Ana María Gómez Jaramillo; Carlos Barba-Ostria; Doménica Cevallos-Robalino; Hugo Sanches-SanMiguel; Luis Unigarro; Rasa Zalakeviciute; Naomi Gadian; Andrés López-Cortés
Journal:  Diagn Microbiol Infect Dis       Date:  2020-05-30       Impact factor: 2.803

4.  Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.

Authors:  Yoshikazu Honda-Okubo; Dale Barnard; Chun Hao Ong; Bi-Hung Peng; Chien-Te Kent Tseng; Nikolai Petrovsky
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

5.  Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitro.

Authors:  Jennifer L Harcourt; Lia M Haynes
Journal:  J Vis Exp       Date:  2013-02-07       Impact factor: 1.355

6.  The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis.

Authors:  Kim-Tat Teoh; Yu-Lam Siu; Wing-Lim Chan; Marc A Schlüter; Chia-Jen Liu; J S Malik Peiris; Roberto Bruzzone; Benjamin Margolis; Béatrice Nal
Journal:  Mol Biol Cell       Date:  2010-09-22       Impact factor: 4.138

7.  Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Authors:  Domizia Baldassi; Bettina Gabold; Olivia Merkel
Journal:  Adv Nanobiomed Res       Date:  2021-05-06

Review 8.  Host-pathogen interactions during coronavirus infection of primary alveolar epithelial cells.

Authors:  Tanya A Miura; Kathryn V Holmes
Journal:  J Leukoc Biol       Date:  2009-07-28       Impact factor: 4.962

9.  Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.

Authors:  Jincun Zhao; Jingxian Zhao; Nico Van Rooijen; Stanley Perlman
Journal:  PLoS Pathog       Date:  2009-10-23       Impact factor: 6.823

10.  Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Tomoki Yoshikawa; Terence E Hill; Naoko Yoshikawa; Vsevolod L Popov; Cristi L Galindo; Harold R Garner; C J Peters; Chien-Te Kent Tseng
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.